When Stakeholder Consensus Diverges From Patient Preferences: Selecting Patient‐Reported Outcome Measures (PROMs) for Kidney Replacement Therapy

José Erivelton de Souza Maciel Ferreira
Hemodialysis International · Wiley · 2026-11-10 · DOI: 10.1111/hdi.70124

Аннотация

ABSTRACT The selection of patient‐reported outcome measures for kidney replacement therapy requires more than achieving an overall numerical majority among stakeholders. This editorial examines methodological issues arising from a modified Delphi study that selected the EQ‐5D‐5L and IPOS‐Renal for implementation in a kidney registry. Although the final combination exceeded the predefined consensus threshold among participants who voted, it did not receive support from most consumers with lived experience, who predominantly preferred combinations including the KDQOL‐36. This divergence illustrates how pooled voting can understate stakeholder‐specific differences when one stakeholder group numerically predominates. Additional considerations include the treatment of abstentions and missing votes, the use of open voting after anonymous Delphi rounds, changes in panel participation across rounds, and the distinction between selecting outcome domains and selecting measurement instruments. Replication in other settings should therefore include transparent denominator rules, stakeholder‐specific consensus reporting, meaningful patient participation, anonymous final voting, and local assessment of linguistic validity, cultural relevance, accessibility, respondent burden, and clinical actionability. Patient‐centered measurement requires patients to meaningfully influence what is measured, how it is assessed, and how results inform care.

Читать у издателя →

Похожие статьи